Extension Study of Protocol EV-BR1701 Group B1
Clinical trial NCT07630493 · COMPLETED
Trial details
- NCT number
- NCT07630493
- Sponsor
- Enimmune Corporation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-28
- Primary completion
- 2025-01-05
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.